Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66976 - 67000 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	CFLAR	8837	downregulated	rosiglitazone results in decreased expression of CFLAR mRNA	2q33.1	A24105 A24106
Rosiglitazone	Approved Investigational	CGB3	1082	upregulated	rosiglitazone results in increased expression of CGB3 mRNA	19q13.33	A20515
Rosiglitazone	Approved Investigational	CGN	57530	downregulated	rosiglitazone results in decreased expression of CGN mRNA	1q21.3	A22609
Rosiglitazone	Approved Investigational	CIDEB	27141	downregulated	rosiglitazone results in decreased expression of CIDEB mRNA	14q12	A22609
Rosiglitazone	Approved Investigational	CIDEC	63924	upregulated	rosiglitazone results in increased expression of CIDEC mRNA	3p25.3	A23178
Rosiglitazone	Approved Investigational	CLRN3	119467	downregulated	rosiglitazone results in decreased expression of CLRN3 mRNA	10q26.2	A22609
Rosiglitazone	Approved Investigational	COCH	1690	downregulated	rosiglitazone results in decreased expression of COCH mRNA	14q12	A20427
Rosiglitazone	Approved Investigational	COL1A1	1277	upregulated	rosiglitazone results in increased expression of COL1A1 mRNA	17q21.33	A23178
Rosiglitazone	Approved Investigational	COL5A3	50509	upregulated	rosiglitazone results in increased expression of COL5A3 mRNA	19p13.2	A10216
Rosiglitazone	Approved Investigational	COMMD5	28991	upregulated	rosiglitazone results in increased expression of COMMD5 mRNA	8q24.3	A24111
Rosiglitazone	Approved Investigational	COX6A2	1339	downregulated	rosiglitazone results in decreased expression of COX6A2 mRNA	16p11.2	A22609
Rosiglitazone	Approved Investigational	CPN1	1369	downregulated	rosiglitazone results in decreased expression of CPN1 mRNA	10q24.2	A22609
Rosiglitazone	Approved Investigational	CPS1	1373	downregulated	rosiglitazone results in decreased expression of CPS1 mRNA	2q34	A22609
Rosiglitazone	Approved Investigational	CPT1A	1374	upregulated	rosiglitazone results in increased expression of CPT1A mRNA	11q13.3	A22609
Rosiglitazone	Approved Investigational	CPT1B	1375	upregulated	rosiglitazone results in increased expression of CPT1B mRNA	22q13.33	A24112
Rosiglitazone	Approved Investigational	CTGF	1490	downregulated	rosiglitazone results in decreased expression of CTGF mRNA	6q23.2	A22609
Rosiglitazone	Approved Investigational	CTH	1491	downregulated	rosiglitazone results in decreased expression of CTH mRNA	1p31.1	A22609
Rosiglitazone	Approved Investigational	CTH	1491	upregulated	rosiglitazone results in increased expression of CTH mRNA	1p31.1	A20427
Rosiglitazone	Approved Investigational	CTTN	2017	downregulated	rosiglitazone results in decreased expression of CTTN mRNA	11q13.3	A20427
Rosiglitazone	Approved Investigational	CTTNBP2	83992	downregulated	rosiglitazone results in decreased expression of CTTNBP2 mRNA	7q31.31	A10216
Rosiglitazone	Approved Investigational	CX3CR1	1524	downregulated	rosiglitazone results in decreased expression of CX3CR1 mRNA	3p22.2	A22860
Rosiglitazone	Approved Investigational	CYP1A1	1543	upregulated	rosiglitazone results in increased expression of CYP1A1 mRNA	15q24.1	A22609
Rosiglitazone	Approved Investigational	CYP1A2	1544	upregulated	rosiglitazone results in increased expression of CYP1A2 mRNA	15q24.1	A22609 A20427
Rosiglitazone	Approved Investigational	CYP1B1	1545	upregulated	rosiglitazone results in increased expression of CYP1B1 mRNA	2p22.2	A22609 A20427
Rosiglitazone	Approved Investigational	CYP2A6	1548	downregulated	rosiglitazone results in decreased expression of CYP2A6 mRNA	19q13.2	A22609

Displaying entries 66976 - 67000 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability